Clinical trials
Withdrawn Phase 3 trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Incyte Corporation | 2 |
| Novo Nordisk A/S | 2 |
| AKARI Therapeutics | 1 |
| Amzell | 1 |
| Celgene | 1 |
| Centocor, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Gan and Lee Pharmaceuticals, USA | 1 |
| Janssen Research & Development, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatitis | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Eczema | 2 |
| Skin Diseases | 2 |
| Central Nervous System Diseases | 1 |
| Crohn Disease | 1 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Type 1 | 1 |
| Epileptic Syndromes | 1 |
| Giant Cell Arteritis | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.